These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4664597)

  • 21. Differentiation between type I and type II substrate binding to cytochrome P-450 by variation of temperature.
    Misselwitz R; Jänig GR; Rein H; Buder E; Zirwer D; Ruckpaul K
    Acta Biol Med Ger; 1976; 35(5):K 19-25. PubMed ID: 983603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the hepatic and pulmonary microsomal mixed-function oxidase systems in the rabbit.
    Bend JR; Hook GE; Easterling RE; Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1972 Oct; 183(1):206-17. PubMed ID: 4404113
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of phase transitions in microsomal membranes on energetic characteristics of oxidation].
    Akhrem AA; Eremin AN; Usanov SA; Metelitsa DI
    Biokhimiia; 1978 Sep; 43(9):1578-85. PubMed ID: 719063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome P-450.
    Di Augustine RP; Fouts JR
    Biochem J; 1969 Nov; 115(3):547-54. PubMed ID: 4390924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsomal xenobiotic metabolism in marsupials.
    McManus ME; Ilett KF
    Drug Metab Dispos; 1977; 5(6):503-10. PubMed ID: 21774
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of vitamin B1 deficiency on xenobiotic hydroxylation and lipid peroxidation in rat liver microsomes].
    Sushko LI; Lukienko PI
    Farmakol Toksikol; 1981; 44(1):102-4. PubMed ID: 7262290
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolism of p-nitroanisole and aniline in isolated hepatocytes of streptozotocin-diabetic rats.
    Eacho PI; Weiner M
    Drug Metab Dispos; 1980; 8(6):385-9. PubMed ID: 6109605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The active center of microsomal-N-oxygenases from rabbit liver].
    Hlavica P
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):356-7. PubMed ID: 4253795
    [No Abstract]   [Full Text] [Related]  

  • 29. Structural properties of rough and smooth microsomal membranes. A study with fluorescence probes.
    Dallner G; Azzi A
    Biochim Biophys Acta; 1972 Feb; 255(2):589-601. PubMed ID: 5057936
    [No Abstract]   [Full Text] [Related]  

  • 30. On the formation of cytochrome P-450 product complexes during the metabolism of phenylalkylamines.
    Jonsson J; Lindeke B
    Acta Pharm Suec; 1976; 13(4):313-20. PubMed ID: 998274
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the mechanism of hepatic microsomal N-oxide formation. N-oxidation of NN-dimethylaniline by a reconstituted rabbit liver microsomal cytochrome P-448 enzyme system.
    Hlavica P; Hülsmann S
    Biochem J; 1979 Jul; 182(1):109-16. PubMed ID: 115464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of rat cytochromes P450 metabolizing N-(2-methoxyphenyl)hydroxylamine, a human metabolite of the environmental pollutants and carcinogens o-anisidine and o-nitroanisole.
    Naiman K; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2010; 31 Suppl 2():36-45. PubMed ID: 21187827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity of ligands other than triarylethylenes for liver microsomal antiestrogen binding sites.
    Ruenitz PC; Bagley JR
    Biochem Pharmacol; 1985 Aug; 34(15):2807-9. PubMed ID: 4015717
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatic microsomal metabolism of drugs during pregnancy in the rat.
    Dean ME; Stock BH
    Drug Metab Dispos; 1975; 3(5):325-31. PubMed ID: 241612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior of various microsomal drug oxidations following inactivation of cytochrome P-450 by UV-irradiation or by deoxycholate treatment].
    Uehleke H; Schnitger F; Hellmer KH
    Hoppe Seylers Z Physiol Chem; 1969 Oct; 350(10):1176-7. PubMed ID: 5352344
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhancement of aniline hydroxylation in human liver microsomes.
    Kitada M; Hasunuma Y; Rikihisa T; Kanakubo Y
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):101-16. PubMed ID: 3081974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanism of inhibition of rat liver microsomal monooxygenases during the development of cholestasis].
    Zakharova NE; Pospelova LN; Gromova OA; Tsyrlov IB; Liakhovich VV
    Vopr Med Khim; 1977; 23(2):181-5. PubMed ID: 883154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species and sex differences in selenium inhibition of hepatic drug metabolism in rodents.
    Merrick BA; Johnson KL; Kester KA; Davies MH; Schnell RC
    Drug Chem Toxicol; 1983; 6(4):329-40. PubMed ID: 6617529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsomal flavoprotein-catalyzed N-oxidation of arylamines.
    Ziegler DM; McKee EM; Poulsen LL
    Drug Metab Dispos; 1973; 1(1):314-21. PubMed ID: 4149399
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of x-irradiation on drug-metabolizing enzyme systems in liver microsomes of male and female rats.
    Nakazawa T; Yukawa O; Ushijima S; Fujimori S
    Radiat Res; 1976 May; 66(2):373-83. PubMed ID: 1265227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.